Related Experiment Video
Updated: Jun 4, 2026
06:28
E-Patient Counseling Trial (E-PACO): Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
Can a bowel preparation exacerbate heart failure?
1Department of Internal Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA. kalindi.parikh@jeffersonhospital.org
Cleveland Clinic Journal of Medicine
|March 3, 2011
Summary
Polyethylene glycol (PEG) solutions for colonoscopy may increase plasma volume in heart failure patients, contrary to theory. This review compares PEG and sodium phosphate preparations for safety in these individuals.
Area of Science:
- Gastroenterology
- Cardiology
- Pharmacology
Background:
- Polyethylene glycol (PEG) solutions are standard for colonoscopy bowel preparation.
- PEG solutions are theoretically non-absorbable and do not alter fluid balance.
- However, studies suggest PEG solutions can increase plasma volume.
Purpose of the Study:
- To compare PEG and sodium phosphate bowel preparations.
- To evaluate the effects of these preparations on patients with heart failure.
- To provide recommendations for colonoscopy in heart failure patients.
Main Methods:
- Literature review comparing PEG and sodium phosphate bowel preparations.
- Analysis of studies reporting effects on plasma volume and heart failure patients.
- Synthesis of findings to formulate clinical recommendations.
Main Results:
- PEG solutions may lead to plasma volume expansion.
- Sodium phosphate solutions also carry risks, particularly fluid and electrolyte shifts.
- The impact on patients with compromised cardiac function requires careful consideration.
Conclusions:
- Patients with heart failure may be at increased risk from plasma volume changes induced by PEG solutions.
- Both PEG and sodium phosphate bowel preparations require cautious use in heart failure patients.
- Individualized risk assessment and preparation selection are crucial for safe colonoscopy in this population.
Related Concept Videos
01:30Heart Failure VII: Nursing Interventions
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:28Imaging Studies for Cardiovascular System V: CT
Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
01:22Heart Failure Drugs: β-Blockers
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...